Pressure BioSciences Closes $800,000 Private Placement | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pressure BioSciences today announced the closing of an $800,000 private placement.

The company sold units consisting of a total of 971,867 shares of restricted common stock and 485,937 warrants to purchase restricted common stock. Each unit consists of one share of restricted common stock and a warrant to purchase one-half share of common stock

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.